Call for Abstract
5th International Conference on Influenza and Zoonotic Diseases, will be organized around the theme “Research Redefined: New horizons in mitigation of Influenza and Zoonotic Diseases”
Influenza 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Influenza 2019
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Influenza virus moves to humans initially by infecting the animals, where the animals infect the humans in some cases eventually spreading through human contact resulting in an epidemic. This has been established by World Health Organization. Influenza virus is generally transmitted through wild birds to other species which leads into an outbreak of human influenza pandemic. New human influenza strains are the result of emergence of different strains of the viruses in poultry and pigs. Influenza pandemic is epidemic of influenza which spreads and infects large number of population worldwide leading to high levels of mortality. Unlike regular epidemics of influenza, it does not occur regularly.
- Track 1-1Spanish Flu
- Track 1-2Avian Flu
- Track 1-3Hong Kong Flu
- Track 1-4Russian Flu
- Track 1-5H1N1 flu
- Track 1-6Other Pandemic Threats
- Track 1-7Nature of Flu Pandemic
The Flu or influenza is caused by influenza virus. Influenza A virus spreads throughout the world usually because of the migration of birds. These strains are resistant to human immunity which is acquired for the other strains, this may result into an epidemic. Influenza virus also spreads by touching the contaminated surfaces and then touching mouth or nose. To prevent this, early vaccination is recommended which is effective against three to four influenza viruses.
- Track 2-1Types of Influenza Virus
- Track 2-2Pathogenesis of Influenza Virus
- Track 2-3Evolution and Virulence
- Track 2-4Neglected Influenza Virus
In an infected stage, host uses two strategies to deal with it i.e. by reducing pathogen impact through which a tolerant host regains fitness or by eliminating the pathogen by which the resistant host can regain fitness. If the host is not able to tolerate or reduce the pathogenic burden, he or she is more susceptible to the infection.
- Track 3-1Virus Structure Organisation
- Track 3-2Genome Organisation
- Track 3-3Influenza cycle in animals and humans
- Track 3-4Host Pathogenic Interaction
- Track 3-5Maternal Immunization
- Track 3-6Viral Proteins
The common symptoms of influenza are respiratory illness such as cough, fever, running nose, sore throat etc. Few people may have respiratory illness but others symptoms may be absent. Traditionally conventional viral cultures are used as standard for diagnosis of influenza which is used as a method of comparison for commercial assays. Rapid culture techniques are in practice for respiratory viruses.
- Track 4-1Factors affecting detection of influenza virus
- Track 4-2Infection Control and Hospital Epidemiology
- Track 4-3Biologics for Flu
- Track 4-4Antimicrobial Resistance
- Track 4-5Therapeutic Approach to Combat Flu
- Track 4-6Pediatric Influenza and its Treatment
The most effective way to prevent the infection of influenza virus is vaccination. Planning the supply of vaccines for healthcare is very important along with the development and production of the vaccine. WHO has been collaborating with scientists on global level for developing, manufacturing and testing and also distributing the influenza vaccine for efficient use for more than 50 years.
- Track 5-1Existing Influenza Vaccination Schemes
- Track 5-2A Universal Influenza Vaccine
- Track 5-3New Approaches in Vaccination
- Track 5-4Evaluation of Vaccine Safety and Effectiveness
- Track 5-5Antimicrobial effect on humans and animals
Development of new drugs against influenza has been of great interest. Number of drugs show Anti-influenza properties, but may have altered effects for the use in clinic. These drugs target viral components and some target the host cell elements which help in the viral cycle, but related side effects are the disadvantages. As for now, four antiviral drugs have been discovered against influenza; zanamivir and oseltamivir which inhibit neuraminidase which act in both Influenza A and Influenza B, while rimantadine and amantadine block M2 passage of influenza A.
- Track 6-1Clinical trials
- Track 6-2Influenza and pneumonia
- Track 6-3Influenza immunization
- Track 6-4Ethical preparedness
A continuous antigenic drift is observed in influenza virus, Therefore vaccines that are to be used should be designed periodically for different strains of viruses along with the wild type of viruses which are found in particular season. Preparation for the pandemic which may result from antigenic shifts that are currently unavailable in human population is necessary.
- Track 7-1Risk Management and Mitigation
- Track 7-2Intervention Stratergies
- Track 7-3Pandemic Preparedness
- Track 7-4Influenza Prevention in Developing Countries
Infectious diseases which are spread between humans and animals are known as zoonotic diseases. These are generally caused by fungi, microbes, parasites etc. which may result into illness in animals and humans which may even have mortal effects. Few animals may be the carrier of such pathogens, they may not be the sufferer but the people coming in contact with these animals may be sick.
- Track 8-1Microbial infections in humans and animals
- Track 8-2Repositories
- Track 8-3Overlooked
- Track 8-4Resistance
Developing zoonotic ailments have possibly genuine human wellbeing and monetary effects and their current upwards slants are probably going to proceed. Cases are avian flu, Bovine Spongiform Encephalitis (BSE) and the Nipah infection. A portion of the "waiting" zoonoses are re-rising in a few districts, in spite of the fact that they appear to draw in less open mindfulness. Brucellosis, puppy rabies and parasitic ailments, for example, cysticercosis/taeniasis and echinococcosis/hydatidosis for instance.
- Track 9-1Types of Zoonotic Disease
- Track 9-2Modes of Transmission
- Track 9-3 Xenotransplantation effect
- Track 9-4Epidemiology and Pathology of Zoonotic Disease
Mostly people are infected by direct contact with the infected animals, by eating them or being bitten by them or the insect that has been in contact with the infected animal recently. In some cases people are infected by coming in contact with contaminated soil or water. Food is one of the chief sources of zoonotic diseases. Eating infected food with parasites such as bacteria, salmonella and tapeworms has resulted in millions of infections each year.
- Track 10-1Severe Acute Respiratory Syndrome
- Track 10-2Kala-Azar
- Track 10-3West Nile Fever
- Track 10-4Valley Fever
- Track 10-5Chikungunya
- Track 10-6Rat White Fever
- Track 10-7Anthrax
- Track 10-8Zika Virus
- Track 10-9Nipah Virus
- Track 10-10Middle East Respiratory Syndrome
Influenza virus consists of eight ssRNA segments coated with viral nucleoproteins molecules which represent beads on string model. The size of these segments is approximately ~0.9 to 2.3 kb and the total genome size is 13.5 kb approximately. The viral RNA genome consists of 12 and 13 conserved nucleotides at 3` and 5` ends which bind to each other and form a pan-handle like structure associated with RNA polymerase.
- Track 11-1Anatomy Pathology Studies
- Track 11-2Histology Studies
- Track 11-3Etiology of the Disease
- Track 11-4Genetic Studies
- Track 11-5Pathogenesis and Host Immune System
- Track 11-6Antigenic variation/ antibody response
- Track 11-7Vectors:Structure and Genetic Organisation
Human medicine has not discovered the role of animals in transmission of zoonotic diseases same as veterinary medicine do not insure clinical features of human disease. It is necessary that physicians and veterinarians work hand in hand to control the zoonotic diseases. Physicians usually do not study the importance of animals in disease transmission whereas the veterinarians lack the training in aspects of clinical trials of human diseases.
- Track 12-1Animal Flu Ecology
- Track 12-2Animal modelling and veterinary infections
- Track 12-3Animal Husbandry Practices & its Impact
- Track 12-4Animal Testings in Infectiology
- Track 12-5Tropical Diseases
- Track 12-6Diseases of Man from Pets
Tracking and listing the information gathered from diseases observed in domestic and wild animals with humans suffering from illness is important. We can attain control in preventing and minimizing the impact of infection that can come into contact with such outbreaks if we have proper knowledge about the infection. People with compromised immunity such as people suffering from AIDS or those are chronically ill are at higher risk of such diseases. To decrease the risk of zoonotic diseases strict guidelines must be followed
- Track 13-1Vaccines Against Zoonotic Disease
- Track 13-2Novel Approaches Towards Vaccination
- Track 13-3Oral Vaccination
- Track 13-4Parental Vaccination
- Track 13-5Precaution for healthcare workers
- Track 13-6Therapeutic strategies
- Track 13-7Effect of climate on parasite host assemblage
- Track 13-8Influenza like illness
- Track 13-9Marbug Virus Paradigm
Disease surveillance is basically collection, distribution, dissemination of information and interpretation of a particular disease. Surveillance is important as it can help in detecting the occurrence of disease which will benefit in reducing the economic loss, the sickness and mortality which can be attained by integrating animal and human health system. It will also help in making inventions that can control the outbreak of zoonotic disease.
- Track 14-1Monitoring Strategies
- Track 14-2Elements of Surveillance System
- Track 14-3Role of International Agencies Involved
- Track 14-4Bio security
- Track 14-5Public Health Inspection
The vaccine production market is one of the most profitable investment options. Increase in number of pet owners, and their concern about maintaining good animal practices are the other reason for the market growth. But on the other hand, government intervention in distribution channel is responsible for the loss of vaccine productions. Purchasing vaccines in bulk for livestock supply are resulting in decreasing the revenue margins of vaccine producers by bulk pricing.
- Track 15-1Market Share of Influenza Vaccine
- Track 15-2Flu Drugs in Global Market
- Track 15-3Industry Share of Antivirals
- Track 15-4Market share of Zoonotic Disease and Drugs
- Track 15-5Research Status in Influenza Zoonotic Disease
Increase in livestock diseases and increasing populations has resulted in growth of market. Awareness about vaccination has escalated, but the consequence is higher costs of storage of vaccine has opened gates for many new ideas thus making a way for new entrepreneurs.
- Track 16-1Cost Effective Solutions in Healthcare
- Track 16-2Developing Curriculum in Public Healthcare Entrepreneurship
People who are in contact with animals, agricultural workers, slaughterhouse workers, ranchers, veterinarians are in high risk of being infected by zoonotic disease. Teaching correct diagnostic techniques about zoonotic diseases to the livestock owners and other people which are in contact with animals can help in reducing the outbreak of disease.
- Track 17-1Daily Habits to Prevent Flu
- Track 17-2Precautionary Measures In case of Outbreaks
- Track 17-3Proper Animal Care Practices
- Track 17-4Emergency Contacts in the Case of Epidemiology